Προφιλ ιατρού

• Πτυχίο Ιατρικής, Τμήμα Ιατρικής, Σχολή Επιστημών υγείας, Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ), Θεσσαλονίκη.
• Ειδικότητα Εσωτερικής Παθολογίας, Πανεπιστημιακό Νοσοκομείο Λωζάνης Ελβετίας, Centre Hospitalier Universitaire Vaudois (CHUV).
• Ειδικότητα Παθολογικής Ογκολογίας, Πανεπιστημιακό Νοσοκομείο Γενεύης Ελβετίας, Hôpitaux Universitaires de Genève (HUG).
• Fédération Médicale Helvétique (FMH) specialty titles.
• ESMO Board Certification.
• Good Clinical Practice (GCP) certification.
• SAKK (Swiss Group for Clinical Cancer Research) activity.
• Διδάκτωρ Πανεπιστημίου Γενεύης (UNIGE).

Faculty of Medicine, University of Geneva, Switzerland with title: The first comprehensive genomic characterization of rectal squamous cell carcinoma, μετά από υποτροφία που αποδόθηκε από το Πανεπιστήμιο της Γενεύης για την πραγματοποίηση των μοριακών αναλύσεων (Next Generation Sequencing 400, Oncoscan-Copy Number Variations, HPV-polymerase Chain Reaction).

• Επί του παρόντος : Ειδικός Ογκολόγος, επιστημονικός συνεργάτης τμήματος Παθολογικής Ογκολογίας, ΙΑΣΩ Θεσσαλίας, Λάρισα.
• τ. Επιμελητής Ογκολογικής Κλινικής Πανεπιστημιακού Νοσοκομείου Γενεύης Ελβετίας (HUG).
• τ. Επιμελητής Ογκολογικής Κλινικής Πανεπιστημιακού Νοσοκομείου Φριμπούργκ Ελβετίας (HFR).
• τ. Ειδικευόμενος ιατρός σε κλινικές Ογκολογίας, Αιματολογίας, Εσωτερικής Παθολογίας, Επειγόντων Περιστατικών Παρηγορητικής Θεραπείας στο Πανεπιστημιακό Νοσοκομείο της Λωζάνης (CHUV).
• τ. Υπεύθυνος ιατρός της Φρουράς της πόλης της Δράμας στη μονάδα της 5ης Μοίρας των Καταδρομών.  
• τ. Υπεύθυνος ιατρός κατασκηνώσεως ΧΑΝ (YMCA) Αγίου Ιωάννη Πηλίου.

• Ανοσοθεραπεία, στοχευμένες θεραπείες, εξατομικευμένη (Personalized Oncology) και προληπτική ογκολογία, εκτίμηση κινδύνου κληρονομικού καρκίνου, ογκολογική γενετική.
• Ολιστική προσέγγιση του ογκολογικού ασθενή, ψυχο-ογκολογία, παρηγορητική/υποστηρικτική φροντίδα τελικού σταδίου.
• Συμβούλια λήψης ογκολογικών αποφάσεων (Μultidisciplinary Tumorboards).
• Ερευνητικά πρωτόκολλα κλινικές μελετών.
• Κλινική καθημερινή ογκολογική πρακτική.

Συμμετοχή ως investigator και sub-investigator σε κλινικά πρωτόκολλα βασικής και εφαρμοσμένης κλινικής έρευνας (μελέτες φάσης Ι, ΙΙ, ΙΙΙ)

-The first comprehensive genomic characterization of rectal squamous cell carcinoma

Journal of Gastroenterology

Christoforos Astaras¹, Claudio De Vito ², Prasad Chaskar², Aurelie Bornand², Kaouthar Khanfir³, Amedeo Sciarra⁴, Igor Letovanec⁴, Claudia Corro^1,5,6, Pierre-Yves Dietrich^1,5,6, Petros Tsantoulis ^1,6, Thibaud Koessler^1,5.

¹Medical Oncology department, Geneva University Hospitals, Switzerland. ²Pathology department, Geneva University Hospitals, Switzerland. ³Radiation Oncology department, Valais Hospital, Sion, Switzerland. ⁴Histopathology, Central Institute, Valais Hospital, Sion, Switzerland. ⁵Swiss Cancer Center Léman, Geneva and Lausanne, Switzerland. ⁶Translational Research Center in Onco-Hematology, Department of Medicine, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland.

-Squamous Rectal Carcinoma: a rare malignancy, literature review and management recommendations.

ESMO-Open

Christoforos Astaras¹, Aurèlie Bornand²,Thibaud Koessler ¹.

¹Department of Oncology, Hopitaux Universitaires de Genève, HUG, Switzerland ²Department of Clinical Pathology, University Hospital of Geneva (HUG), Geneva, Switzerland

-The Screening and COnsensus Based on Practices and Evi-dence (SCOPE) Program Results of a Survey on Daily Practice Patterns for Patients with Metastatic Colorectal Cancer—A Swiss Perspective in the Context of an International Viewpoint

Current Oncology

Alexander R Siebenhüner^a, Giorgia Lo Presti^b, Daneil Helbling^c, Petr Szturz^d, Christoforos Astaras^e, Yannick Buccel-la^f and Sara De Dosso^g

^a Department of Medical Oncology and Hematology, Cantonal Hospital Schaffhausen, Geissbergstrasse 81, Schaffhausen/Canton; [email protected] ^b Ente Ospedaliero Cantonale, Via All’Ospedale 1, Locarno/Canton Ticino; [email protected] ^c Institute: Gastrointestinales Tumorzentrum Zürich; [email protected] ^d University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Lausanne, Switzerland; [email protected] ^e Insitute: HUGE, Geneva University Hospitals; [email protected] ^f Institute: Stadtspital Zürich Triemli; [email protected] ^g Department of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland, and Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland; [email protected]

-La vitamine C haute dose intraveineuse a-t-elle un effet antitumoral ?

Revue Médicale Suisse

Marie-Gabrielle Courtes¹, Nathalie Baudoux¹, Christoforos Astaras¹, Eugenio Fernandez¹

¹Service d’Oncologie Médicale, Département d’Oncologie, Hôpitaux Universitaires de Genève (HUG), Rue Gabrielle Perret-Gentil 4, 1205 Genève

-Where are we now and where might we be heading in understanding and managing brain metastases in colorectal cancer patients?

Current Treatment Options in Oncology

Ribal Boumjahed¹, Christoforos Astaras¹, Thibaud Koessler¹, Arnaud Roth¹

¹Department of Oncology, HopitauxUniversitaires de Geneve, HUG, Switzerland

-UNcommon EGFR mutations: International Case series on efficacy of osimertinib in Real-life practice in first liNe setting (UNICORN)

Journal of Thoracic Oncology

Alfredo Addeo¹, Jair Bar², Mira Wollner³,Elizabeth Dudnik ⁴, Nir Peled⁵, Dror Limon⁶, Hasna Bouchaab⁷, Christoforos Astaras¹, Amina Scherz⁸, Kristof Cuppens⁹, Lynn Decoster¹⁰, Sofie Derijcke¹¹, Peter Meldgaard¹²

1:Hôpitaux universitaires Genève, Rue Gabrielle-Perret-Gentil 4, 1205 Genève, 2: Sheba MC, RamatGan, Israel, 3: Rambam, Haifa, Israel, 4: Davidoff cancer center, Belinson MC, PetahTikva, Israel, 5: Soroka MC, Be’erSheva, Israel, 6: Sourasky MC, Tel Aviv, Israel, 7: Centre hospitalier universitaire vaudois, Département d'oncologie UNIL-CHUV, Lausanne, 8: Universitätsspital Bern, UniversitätsklinikfürMedizinischeOnkologie, 9:Jessa Ziekenhuis, Hasselt, Belgium, 10: AZ Turnhout, Campus Sint-Elisabeth, Turnhout, Belgium, 11: AZ Groeninge, Kortrijk, Belgium, 12: Aarhus University Hospital, Oncology dept. team C, Aarhus.

-The Rapidly Changing Treatment Landscape of Systemic Therapy for HER-2 Positive Metastatic Breast Cancer.

healthbook TIMES Oncology Hematology

Larissa Russo-Vorms¹, Christoforos Astaras¹, José Sandoval¹, Maxime Borgeaud ¹, Alexandre Bodmer¹

Department of Oncology, Hopitaux Universitaires de Genève, HUG, Switzerland

-Advanced gastric cancer – current treatment landscape and a future outlook for sequential and personalized guide– Swiss Expert statement paper.

Oncology Research and Treatment

Alexander Siebenhüner ^{1, 10}, Sara De Dosso², Daniel Helbling³, Christoforos Astaras⁴, Petr Szturz⁵, Peter Moosmann⁶, Stefanie Pederiva⁷, Thomas Winder³, Philippe Von Burg⁸, Markus Borner⁹

¹Clinic for Medical Oncology and Hematology, University Hospital Zurich and University Zurich, Zurich, Switzerland, ²Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland, ³OnkoZentrum Zürich, Zürich, Switzerland, ⁴Geneva University Hospitals (HUG), Geneva, Switzerland, ⁵Lausanne University Hospital (CHUV), Lausanne, Switzerland, ⁶Cantonal Hospital Aarau, Aarau, Switzerland, ⁷Cantonal Hospital Baden, Baden, Switzerland, ⁸Bürgerspital Solothurn, Solothurn, Switzerland, ⁹ONCOCARE AG Oncology Centre in the KlinikEngeried, Bern, Switzerland, ¹⁰ Cantonal Hospital Schaffhausen, Schaffhausen, Switzerland

-UNcommon EGFR mutations: International Case series on efficacy of Osimertinib in Real-life practice in first liNe setting (UNICORN study).

Annals of Oncology and Poster for ESMO 2021 congress

J. Bar, W. Kian, M. Wolner, S. Derijcke, N. Girard, Y. Rottenberg, E. Dudnik, G. Metro, M. Hochmair, F. Aboubakar, K. Cuppens, L. Decoster, M. Reck, D. Limon, A. Calles, Blanco, C. Astaras, S. Häfliger, N. Peled, A. Addeo

-Recent advances in Gastro-intestinal cancers.

World Journal of Gastroenterology

Natacha Bordry¹, Christoforos Astaras¹, Marie Ongaro², Nicolas Goossens ², Jean Louis Frossard² and Thibaud Kossler¹

¹Department of Oncology, University Hospital of Geneva (HUG), Geneva, Switzerland ² Divison of gastro-enterology and hepatology, University Hospital of Geneva (HUG), Geneva, Switzerland

-La place de l’immunothérapie en oncologie digestive.

Revue Médicale Suisse

Anaïs Saur¹, Thibaud Koessler^1,2, Christoforos Astaras¹

¹ Service d’Oncologie Médicale, Département d’Oncologie, Hôpitaux Universitaires de Genève (HUG), Rue Gabrielle Perret-Gentil 4, 1205 Genève ²SwissCacner Center Leman. AGORA Pôle de recherche sur le cancer, Rue du Bugnon 25A, CH-1005 Lausanne, Switzerland

-Treatment landscape of advanced pancreatic cancer: Current options for Swiss patients.

Cancer Treatment Reviews

Sara De Dosso¹, Alexander R. Siebenhüner², Thomas Winder³, Alexander Meisel⁴, Ralph Fritsch⁴, Christoforos Astaras⁵, Petr Szturz⁶, and Markus Borner ⁷

¹Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland, ²Cantonal Hospital Schaffhausen, Schaffhausen, Switzerland, ³Swiss Tumor Molecular Institute, OnkoZentrum, Zurich, Switzerland, ⁴University Hospital Zurich, Zurich, Switzerland, ⁵Geneva University Hospitals (HUG), Geneva, Switzerland, ⁶Lausanne University Hospital (CHUV), Lausanne, Switzerland, ⁷Oncocare, Engeriedspital, Engeried, Switzerland

-Proton therapy of a conjunctival carcinoma in the anophthalmic socket, 41 years after enucleation for a sporadic retinoblastoma. A case report and review of the literature.

Klinische Monatsblatt fur augenheikunde

Moulin¹, A. Pica.^{1, 2}, F. Munier¹, A. Schalenbourg¹, A. Nobile ³, A. Asanau⁴, C. Astaras⁴, M. Hamedani¹

1: Jules-Gonin Eye Hospital, Lausanne University, Department of Ophthalmology, FAA, 15 Avenue de France, 1004 Lausanne, 2: Paul Scherrer Institute, Forschungsstrasse 111, 5232 Villigen, 3: Promed, Route de l’Ancienne papeterie 131, 1723 Marly, 4: Fribourg District Hospital, Case postale, 1708 Fribourg

-Response to Osimertinib in a Patient with Non-Small Cell Lung Cancer and Two   Uncommon EGFR Mutations.

Healthbook TIMES Oncology Hematology

Christoforos Astaras, Adrienne Bettini, Daniel C. Betticher

Department of Oncology, HFR Fribourg Hospital, 1700 Fribourg, Switzerland

-La biopsie liquide, une nouvelle opportunité pour l’oncologie personnalisée

La Revue Médicale Suisse

Christoforos Astaras¹, Ana Dolcan¹, Bettina Bisig¹, Khalil Zaman¹

Service d’oncologie médicale, Département d'oncologie, CHUV, 1011 Lausanne

-Functional metastatic adrenocortical carcinoma in durable complete remission- Case report and literature.

Open Journal of Clinical and Medical Case Reports

Christoforos Astaras¹, Keyvan Shabafrouz ¹, Hasna Bouchaab¹, Dominik Berthold¹

CHUV Lausanne University Hospital of Lausanne, Department of Oncology, 1011 Lausanne, Switzerland

-Neurological adverse events associated with immune checkpoint inhibitors: Diagnosis and management.

Current Neurology and Neuroscience Reports

Christoforos Astaras¹, Rita de Micheli¹, Bianca Moura¹, Thomas Hundseberger², Andreas Hottinger¹

¹CHUV Lausanne University Hospital and Lausanne Univerity¹, Departments of Oncology and Clinical Neurosciences, 1011 Lausanne, Switzerland ²Department of Neurology, Medical Oncology and Hematology, Cantonal hospital, 9007 Sankt Gallen Switzerland

-Quel est votre diagnostic ?

Cas clinique au journal suisse PRAXIS

Astaras C.¹, Nsangu M.¹, Tschopp O.², Stauffer E.³, Metzener N.¹, Orecchio A.¹, Burnand J. ¹, Schiemann U.¹

Département de la médecine interne¹ et de l’orthopédie², Hôpital de Riaz, Suisse, Institute de pathologie Promed³, Suisse

• Swiss Society of Medical Oncology (SSMO)
• Federation Medicale Helvetique (FMH)
• American Society of Clinical Oncology (ASCO)
• European Society of Medical Oncology (ESMO)
• Hellenic Society of Medical Oncology (HeSMO)
• American Association for Cancer Research (AACR)

Ελληνικά, Αγγλικά, Γαλλικά

ΙΑΣΩ ΘΕΣΣΑΛΙΑΣ (8^Ο χλμ. Π.Ε.Ο. Λάρισας-Αθηνών, 41005, Λάρισα)

28^ης Οκτωβρίου 14 & Κούμα γωνία, 41223, Λάρισα

ch.linkedin.com/in/christoforos-astaras-835bb658